Effect of carotene and lycopene on the risk of prostate cancer: A systematic review and dose-response meta-analysis of observational studies

PLoS ONE

Volumn 10, Issue 9, 2015, Pages

  Wang, Yulan ^a   Cui, Ran ^a   Xiao, Yuanyuan ^a   Fang, Juemin ^a   Xu, Qing ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA CAROTENE; BETA CAROTENE; LYCOPENE; CAROTENOID;

ARTICLE; BLOOD SAMPLING; CANCER PREVENTION; CANCER RISK; CASE CONTROL STUDY; COHORT ANALYSIS; DIET THERAPY; DISEASE ASSOCIATION; FOOD COMPOSITION; HUMAN; META ANALYSIS; PROSTATE CANCER; RISK REDUCTION; SYSTEMATIC REVIEW; TREATMENT RESPONSE; VITAMIN BLOOD LEVEL; DOSE RESPONSE; MALE; OBSERVATIONAL STUDY; PROSTATIC NEOPLASMS; RISK;

CAROTENOIDS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; MALE; OBSERVATIONAL STUDIES AS TOPIC; PROSTATIC NEOPLASMS; RISK;

EID: 84945934616     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0137427     Document Type: Article

References (70)

1. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011; 61:69-90. doi: 10.3322/caac.20107 PMID: 21296855
2. Potosky AL, Miller BA, Albertsen PC, Kramer BS. The role of increasing detection in the rising incidence of PCa. JAMA. 1995; 273:548-52. PMID: 7530782
3. Nomura AM, Kolonel LN. Prostate cancer: a current perspective. Epidemiol Rev. 1991; 13:200-27. PMID: 1765112
4. World Cancer Report 2014. World Health Organization. 2014. pp. Chapter 5.11. ISBN 9283204298.
5. PCa Statistics-Australia. http://www.prostates.com.au/statistics/.
6. Lee MM, Gomez SL, Chang JS, Wey M, Wang RT, Hsing AW. Soy and isoflavone consumption in relation to PCa risk in China. Cancer Epidemiol Biomarkers Prev. 2003; 12:665-8. PMID: 12869409
7. World Health Organization. Noncommunicable Diseases Country Profiles 2011. Geneva: World Health Organization; 2011. p. 50.
8. Bolhassani A. Cancer chemoprevention by natural carotenoids as an efficient strategy. Anticancer Agents Med Chem. 2015. [Epub ahead of print].
9. Stahl W, Sies H. beta-Carotene and other carotenoids in protection from sunlight. Am J Clin Nutr. 2012; 96:1179S-84S. doi: 10.3945/ajcn.112.034819 PMID: 23053552
10. Viuda-Martos M, Sanchez-Zapata E, Sayas-Barbera E, Sendra E, Perez-Alvarez JA, Fernandez-Lopez J. Tomato and tomato byproducts. Human health benefits of lycopene and its application to meat products: a review. Crit Rev Food Sci Nutr. 2014; 54:1032-49. doi: 10.1080/10408398.2011. 623799 PMID: 24499120
11. O'Neill ME, Carroll Y, Corridan B, Olmedilla B, Granado F, Blanco I, et al. A European carotenoid database to assess carotenoid intakes and its use in a five-country comparative study. Br J Nutr. 2001; 85:499-507. PMID: 11348565
12. Krinsky NI. The antioxidant and biological properties of the carotenoids. Ann N Y Acad Sci.1998; 854:443-7. PMID: 9928451
13. Peto R, Doll R, Buckley JD, Sporn MB. Can dietary beta-carotene materially reduce human cancer rates? Nature. 1981; 290:201-8. PMID: 7010181
14. Shibata A, Paganini-Hill A, Ross RK, Henderson BE. Intake of vegetables, fruits, beta-carotene, vitamin C and vitamin supplements and cancer incidence among the elderly: a prospective study. Br J Cancer. 1992; 66:673-9. PMID: 1419605
15. Andersson SO, Wolk A, Bergstrom R, Giovannucci E, Lindgren C, Baron J, et al. Energy, nutrient intake and prostate cancer risk: a population-based case-control study in Sweden. Int J Cancer. 1996; 68:716-22. PMID: 8980172
16. Schuurman AG, Goldbohm RA, Brants HA, van den Brandt PA. A prospective cohort study on intake of retinol, vitamins C and E, and carotenoids and prostate cancer risk (Netherlands). Cancer Causes Control. 2002; 13:573-82. PMID: 12195647
17. Zhang J, Dhakal I, Stone A, Ning B, Greene G, Lang NP, et al. Plasma carotenoids and prostate cancer: a population-based case-control study in Arkansas. Nutr Cancer. 2007; 59:46-53. PMID: 17927501
18. Sies H, Stahl W, Sundquist AR. Antioxidant functions of vitamins. Vitamins E and C, beta-carotene, and other carotenoids. Ann N Y Acad Sci.1992; 669:7-20. PMID: 1444060
19. Clinton SK, Emenhiser C, Schwartz SJ, Bostwick DG, Williams AW, Moore BJ, et al. cis-trans lycopene isomers, carotenoids, and retinol in the human prostate. Cancer Epidemiol Biomarkers Prev. 1996; 5:823-33. PMID: 8896894
20. World Cancer Research Fund International/American Institute for Cancer Research Continuous Update Project Report:Diet, Nutrition, Physical Activity, and Prostate Cancer. 2014. Available at: www.wcrf.org/sites/default/files/Prostate-Cancer-2014-Report.pdf
21. Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010; 25:603-5. doi: 10.1007/s10654-010-9491-z PMID: 20652370
22. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials.1986; 7:177-88. PMID: 3802833
23. Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002; 21:1539-58. PMID: 12111919
24. Greenland S, Longnecker MP. Methods for trend estimation from summarized dose-response data, with applications to meta-analysis. Am J Epidemiol. 1992; 135:1301-9. PMID: 1626547
25. Orsini N, Bellocco R, Greenland S. Generalized least squares for trend estimation of summarized doseresponse data. Stata Journal. 2006; 6:40-57.
26. Huang HY, Alberg AJ, Norkus EP, Hoffman SC, Comstock GW, Helzlsouer KJ. Prospective study of antioxidant micronutrients in the blood and the risk of developing prostate cancer. Am J Epidemiol. 2003; 157:335-44. PMID: 12578804
27. Peters U, Leitzmann MF, Chatterjee N, Wang Y, Albanes D, Gelmann EP, et al. Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial. Cancer Epidemiol Biomarkers Prev. 2007; 16:962-8. PMID: 17507623
28. McCann SE, Ambrosone CB, Moysich KB, Brasure J, Marshall JR, Freudenheim JL, et al. Intakes of selected nutrients, foods, and phytochemicals and prostate cancer risk in western New York. Nutr Cancer. 2005; 53:33-41. PMID: 16351504
29. Chang S, Erdman JW Jr., Clinton SK, Vadiveloo M, Strom SS, Yamamura Y, et al. Relationship between plasma carotenoids and prostate cancer. Nutr Cancer. 2005; 53:127-34. PMID: 16573373
30. Roswall N, Larsen SB, Friis S, Outzen M, Olsen A, Christensen J, et al. Micronutrient intake and risk of prostate cancer in a cohort of middle-aged, Danish men. Cancer Causes Control. 2013; 24:1129-35. doi: 10.1007/s10552-013-0190-4 PMID: 23519640
31. Umesawa M, Iso H, Mikami K, Kubo T, Suzuki K, Watanabe Y, et al. Relationship between vegetable and carotene intake and risk of prostate cancer: the JACC study. Br J Cancer. 2014; 110:792-6. doi: 10.1038/bjc.2013.685 PMID: 24169341
32. Jian L, Du CJ, Lee AH, Binns CW. Do dietary lycopene and other carotenoids protect against prostate cancer? Int J Cancer. 2005; 113:1010-4. PMID: 15514967
33. Kirsh VA, Hayes RB, Mayne ST, Chatterjee N, Subar AF, Dixon LB, et al. Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk. J Natl Cancer Inst. 2006; 98:245-54. PMID: 16478743
34. Key TJ, Appleby PN, Allen NE, Travis RC, Roddam AW, Jenab M, et al. Plasma carotenoids, retinol, and tocopherols and the risk of prostate cancer in the European Prospective Investigation into Cancer and Nutrition study. Am J Clin Nutr. 2007; 86:672-81. PMID: 17823432
35. Wu K, Erdman JW Jr., Schwartz SJ, Platz EA, Leitzmann M, Clinton SK, et al. Plasma and dietary carotenoids, and the risk of prostate cancer: a nested case-control study. Cancer Epidemiol Biomarkers Prev. 2004; 13:260-9. PMID: 14973107
36. Beilby J, Ambrosini GL, Rossi E, de Klerk NH, Musk AW. Serum levels of folate, lycopene, beta-carotene, retinol and vitamin E and prostate cancer risk. Eur J Clin Nutr. 2010; 64:1235-8. doi: 10.1038/ejcn.2010.124 PMID: 20683458
37. Goodman GE, Schaffer S, Omenn GS, Chen C, King I. The association between lung and prostate cancer risk, and serum micronutrients: results and lessons learned from beta-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prev. 2003; 12:518-26. PMID: 12814997
38. Ambrosini GL, de Klerk NH, Fritschi L, Mackerras D, Musk B. Fruit, vegetable, vitamin A intakes, and prostate cancer risk. Prostate Cancer Prostatic Dis. 2008; 11:61-6. PMID: 17519926
39. Gill JK, Franke AA, Steven Morris J, Cooney RV, Wilkens LR, Le Marchand L, et al. Association of selenium, tocopherols, carotenoids, retinol, and 15-isoprostane F(2t) in serum or urine with prostate cancer risk: the multiethnic cohort. Cancer Causes Control. 2009; 20:1161-71. doi: 10.1007/s10552-009-9304-4 PMID: 19212706
40. Gann PH, Ma J, Giovannucci E, Willett W, Sacks FM, Hennekens CH, et al. Lower prostate cancer risk in men with elevated plasma lycopene levels: results of a prospective analysis. Cancer Res. 1999; 59:1225-30. PMID: 10096552
41. Giovannucci E, Ascherio A, Rimm EB, Stampfer MJ, Colditz GA, Willett WC. Intake of carotenoids and retinol in relation to risk of prostate cancer. J Natl Cancer Inst.1995; 87:1767-76. PMID: 7473833
42. Mettlin C, Selenskas S, Natarajan N, Huben R. Beta-carotene and animal fats and their relationship to prostate cancer risk. A case-control study. Cancer. 1989; 64:605-12. PMID: 2743255
43. Bosetti C, Talamini R, Montella M, Negri E, Conti E, Franceschi S, et al. Retinol, carotenoids and the risk of prostate cancer: a case-control study from Italy. Int J Cancer. 2004; 112:689-92. PMID: 15382052
44. Norrish AE, Jackson RT, Sharpe SJ, Skeaff CM. Prostate cancer and dietary carotenoids. Am J Epidemiol. 2000; 151:119-23. PMID: 10645813
45. Nomura AM, Stemmermann GN, Lee J, Craft NE. Serum micronutrients and prostate cancer in Japanese Americans in Hawaii. Cancer Epidemiol Biomarkers Prev. 1997; 6:487-91. PMID: 9232334
46. Agalliu I, Kirsh VA, Kreiger N, Soskolne CL, Rohan TE. Oxidative balance score and risk of PCa: results from a case-cohort study. Cancer Epidemiol. 2011; 35:353-61. doi: 10.1016/j.canep.2010.11.002 PMID: 21145797
47. Cohen JH, Kristal AR, Stanford JL. Fruit and vegetable intakes and PCa risk. J Natl Cancer Inst. 2000; 92:61-8. PMID: 10620635
48. Deneo-Pellegrini H, De Stefani E, Ronco A, Mendilaharsu M. Foods, nutrients and PCa: a case-control study in Uruguay. Br J Cancer. 1999; 80:591-7. PMID: 10408871
49. Hsing AW, Comstock GW, Abbey H, Polk BF. Serologic precursors of cancer. Retinol, carotenoids, and tocopherol and risk of PCa. J Natl Cancer Inst. 1990; 82:941-6. PMID: 2342127
50. Jain MG, Hislop GT, Howe GR, Ghadirian P. Plant foods, antioxidants, and PCa risk: findings from case-control studies in Canada. Nutr Cancer. 1999; 34:173-84. PMID: 10578485
51. Karppi J, Kurl S, Nurmi T, Rissanen TH, Pukkala E, Nyyssonen K. Serum lycopene and the risk of cancer: the Kuopio Ischaemic Heart Disease Risk Factor (KIHD) study. Ann Epidemiol. 2009; 19:512-8. doi: 10.1016/j.annepidem.2009.03.017 PMID: 19443241
52. Lu QY, Hung JC, Heber D, Go VL, Reuter VE, Cordon-Cardo C, et al. Inverse associations between plasma lycopene and other carotenoids and PCa. Cancer Epidemiol Biomarkers Prev. 2001; 10:749-56. PMID: 11440960
53. Meyer F, Bairati I, Fradet Y, Moore L. Dietary energy and nutrients in relation to preclinical PCa. Nutr Cancer. 1997; 29:120-6. PMID: 9427974
54. Daviglus ML, Dyer AR, Persky V, Chavez N, Drum M, Goldberg J, et al. Dietary beta-carotene, vitamin C, and risk of PCa: results from the Western Electric Study. Epidemiology. 1996; 7:472-7. PMID: 8862976
55. Druesne-Pecollo N, Latino-Martel P, Norat T, Barrandon E, Bertrais S, Galan P, et al. Beta-carotene supplementation and cancer risk: a systematic review and metaanalysis of randomized controlled trials. Int J Cancer. 2010; 127:172-84. doi: 10.1002/ijc.25008 PMID: 19876916
56. Di Mascio P, Kaiser S, Sies H. Lycopene as the most efficient biological carotenoid singlet oxygen quencher. Arch Biochem Biophys. 1989; 274:532-8. PMID: 2802626
57. Etminan M, Takkouche B, Caamano-Isorna F. The role of tomato products and lycopene in the prevention of PCa: a meta-analysis of observational studies. Cancer Epidemiol Biomarkers Prev. 2004; 13:340-5. PMID: 15006906
58. Rafi MM, Kanakasabai S, Reyes MD, Bright JJ. Lycopene modulates growth and survival associated genes in PCa. J Nutr Biochem. 2013; 24:1724-34. doi: 10.1016/j.jnutbio.2013.03.001 PMID: 23746934
59. Yang CM, Lu YL, Chen HY, Hu ML. Lycopene and the LXRalpha agonist T0901317 synergistically inhibit the proliferation of androgen-independent PCa cells via the PPARgamma-LXRalpha-ABCA1 pathway. J Nutr Biochem. 2012; 23:1155-62. doi: 10.1016/j.jnutbio.2011.06.009 PMID: 22137263
60. Zu K, Mucci L, Rosner BA, Clinton SK, Loda M, Stampfer MJ, et al. Dietary lycopene, angiogenesis, and PCa: a prospective study in the prostate-specific antigen era. J Natl Cancer Inst. 2014; 106:djt430. doi: 10.1093/jnci/djt430 PMID: 24463248
61. van Poppel G, Goldbohm RA. Epidemiologic evidence for beta-carotene and cancer prevention. Am J Clin Nutr. 1995; 62:1393S-402S. PMID: 7495237
62. Palozza P, Sestito R, Picci N, Lanza P, Monego G, Ranelletti FO. The sensitivity to beta-carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and PCa cells. Carcinogenesis. 2008; 29:2153-61. doi: 10.1093/carcin/bgn018 PMID: 18635524
63. Watters JL, Gail MH, Weinstein SJ, Virtamo J, Albanes D. Associations between alpha-tocopherol, beta-carotene, and retinol and PCa survival. Cancer Res. 2009; 69:3833-41. doi: 10.1158/0008-5472. CAN-08-4640 PMID: 19383902
64. Murakoshi M, Takayasu J, Kimura O, Kohmura E, Nishino H, Iwashima A, et al. Inhibitory effects of alpha-carotene on proliferation of the human neuroblastoma cell line GOTO. J Natl Cancer Inst. 1989; 81:1649-52. PMID: 2795693
65. Murakoshi M, Nishino H, Satomi Y, Takayasu J, Hasegawa T, Tokuda H, et al. Potent preventive action of alpha-carotene against carcinogenesis: spontaneous liver carcinogenesis and promoting stage of lung and skin carcinogenesis in mice are suppressed more effectively by alpha-carotene than by betacarotene. Cancer Res. 1992; 52:6583-7. PMID: 1423303
66. Li C, Ford ES, Zhao G, Balluz LS, Giles WH, Liu S. Serum alpha-carotene concentrations and risk of death among US Adults: the Third National Health and Nutrition Examination Survey Follow-up Study. Arch Intern Med. 2011; 171:507-15. doi: 10.1001/archinternmed.2010.440 PMID: 21098341
67. Rubin MA, Maher CA, Chinnaiyan AM. Common gene rearrangements in PCa. J Clin Oncol. 2011; 29:3659-68. doi: 10.1200/JCO.2011.35.1916 PMID: 21859993
68. Xue L, Mao X, Ren G, Stankiewicz E, Kudahetti SC, Lin D, et al. Chinese and Western PCas show alternate pathogenetic pathways in association with ERG status. Am J Cancer Res. 2012; 2:736-44. PMID: 23226619
69. Mao X, Yu Y, Boyd LK, Ren G, Lin D, Chaplin T, et al. Distinct genomic alterations in PCas in Chinese and Western populations suggest alternative pathways of prostate carcinogenesis. Cancer Res. 2010; 70:5207-12. doi: 10.1158/0008-5472.CAN-09-4074 PMID: 20516122
70. Shen Y, Lu Y, Yin X, Zhu G, Zhu J. KRAS and BRAF mutations in prostate carcinomas of Chinese patients. Cancer Genet Cytogenet. 2010; 198:35-9. doi: 10.1016/j.cancergencyto.2009.12.003 PMID: 20303012